5,600 Shares in Zimmer Biomet Holdings Inc (ZBH) Purchased by IFM Investors Pty Ltd

IFM Investors Pty Ltd purchased a new stake in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 5,600 shares of the medical equipment provider’s stock, valued at approximately $656,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ZBH. JPMorgan Chase & Co. grew its holdings in shares of Zimmer Biomet by 92.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 3,279,951 shares of the medical equipment provider’s stock worth $421,146,000 after acquiring an additional 1,577,874 shares during the period. Longview Partners Guernsey LTD grew its holdings in shares of Zimmer Biomet by 17.7% during the 3rd quarter. Longview Partners Guernsey LTD now owns 7,506,684 shares of the medical equipment provider’s stock worth $878,958,000 after acquiring an additional 1,128,973 shares during the period. Koch Industries Inc. grew its holdings in shares of Zimmer Biomet by 49,697.3% during the 2nd quarter. Koch Industries Inc. now owns 1,040,764 shares of the medical equipment provider’s stock worth $1,033,000 after acquiring an additional 1,038,674 shares during the period. Alyeska Investment Group L.P. grew its holdings in shares of Zimmer Biomet by 249.3% during the 3rd quarter. Alyeska Investment Group L.P. now owns 1,019,872 shares of the medical equipment provider’s stock worth $119,417,000 after acquiring an additional 727,925 shares during the period. Finally, BlackRock Inc. grew its holdings in shares of Zimmer Biomet by 4.1% during the 2nd quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock worth $2,236,657,000 after acquiring an additional 679,080 shares during the period. 86.24% of the stock is owned by institutional investors and hedge funds.

Zimmer Biomet Holdings Inc (NYSE ZBH) traded down $0.02 during trading on Thursday, hitting $113.52. The company had a trading volume of 2,815,500 shares, compared to its average volume of 1,362,485. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78. The stock has a market cap of $22,988.79, a P/E ratio of 14.07, a P/E/G ratio of 1.76 and a beta of 1.15. Zimmer Biomet Holdings Inc has a 52 week low of $100.81 and a 52 week high of $133.49.

Zimmer Biomet (NYSE:ZBH) last posted its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.74 by ($0.02). The company had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Zimmer Biomet had a return on equity of 16.29% and a net margin of 8.36%. The business’s quarterly revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.79 EPS. research analysts predict that Zimmer Biomet Holdings Inc will post 8.03 earnings per share for the current fiscal year.

A number of research analysts have weighed in on the company. BMO Capital Markets reiterated a “buy” rating and set a $142.00 target price on shares of Zimmer Biomet in a report on Tuesday. TheStreet downgraded Zimmer Biomet from a “b-” rating to a “c+” rating in a report on Friday, November 24th. Zacks Investment Research downgraded Zimmer Biomet from a “hold” rating to a “strong sell” rating in a report on Monday, November 20th. Deutsche Bank upgraded Zimmer Biomet from a “hold” rating to a “buy” rating and set a $128.00 target price on the stock in a report on Tuesday, November 14th. Finally, Edward Jones upgraded Zimmer Biomet from a “hold” rating to a “buy” rating in a report on Thursday, November 9th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $134.05.

ILLEGAL ACTIVITY NOTICE: This article was first published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.truebluetribune.com/2017/12/14/5600-shares-in-zimmer-biomet-holdings-inc-zbh-purchased-by-ifm-investors-pty-ltd.html.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply